republic-os/legislation/us/states/ca/20252026/ab-1152.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Controlled substances: human chorionic gonadotropin.	Existing law, the California Uniform Controlled Substances Act, categorizes controlled substances into 5 schedules and places the greatest restrictions on those substances contained in Schedule I. Under existing law, the substances in Schedule I are deemed to have a high potential for abuse and no accepted medical use while substances in Schedules II through V are substances that have an accepted medical use, but have the potential for abuse. Existing law generally restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified. Existing law categorizes chorionic gonadotropin, including human chorionic gonadotropin (hCG) , as a Schedule III controlled substance except when the hCG is possessed by, sold to, purchased by, transferred to, or administrated by, a licensed veterinarian or a licensed veterinarian's designated agent, exclusively for veterinary use.	us/states/ca	California Legislature	20252026	AB 1152	California AB 1152 (20252026)	bill	Controlledsubstances humanchorionicgonadotropin	enacted	Patterson	7	32	7	2025-02-20	2025-10-01	openstates	ocd-bill/ab80ac3a-9a39-4578-8e1e-3d1bd43a1acd	http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB1152	4b046300069f56df0e9cbb9d90b29c8aba96a3038cac55a39ac38501ad645154	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-ca

California AB 1152 (20252026) — Controlled substances: human chorionic gonadotropin.

Existing law, the California Uniform Controlled Substances Act, categorizes controlled substances into 5 schedules and places the greatest restrictions on those substances contained in Schedule I. Under existing law, the substances in Schedule I are deemed to have a high potential for abuse and no accepted medical use while substances in Schedules II through V are substances that have an accepted medical use, but have the potential for abuse. Existing law generally restricts the prescription, furnishing, possession, sale, and use of controlled substances, and makes a violation of those laws a crime, except as specified. Existing law categorizes chorionic gonadotropin, including human chorionic gonadotropin (hCG) , as a Schedule III controlled substance except when the hCG is possessed by, sold to, purchased by, transferred to, or administrated by, a licensed veterinarian or a licensed veterinarian's designated agent, exclusively for veterinary use.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. 02/20/25 - Introduced (filed) — source
2. 03/28/25 - Amended Assembly (committee substitute) — source
3. 06/23/25 - Amended Senate (committee substitute) — source
4. 09/02/25 - Amended Senate (committee substitute) — source
5. 10/01/25 - Chaptered (committee substitute) — source
6. AB1152 (committee substitute) — source
7. 09/16/25 - Enrolled (enrolled) — source

Votes

• AB 1152 Patterson Concurrence in Senate Amendments — 74–0 (pass) · lower
• Do pass. — 10–0 (pass) · lower
• Do pass, but first be re-referred to the Committee on [Appropriations] with the recommendation: To Consent Calendar — 6–0 (pass) · upper
• With recommendation: That Senate amendments be concurred in. — 9–0 (pass) · lower
• AB 1152 Patterson Assembly Third Reading — 68–0 (pass) · lower
• 3rd Reading AB1152 Patterson By Valladares — 39–1 (pass) · upper
• Do pass and be re-referred to the Committee on [Local Government] with recommendation: To Consent Calendar — 11–0 (pass) · lower

Sponsors

• Patterson — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2025-02-20 Read first time. To print. reading-1
• 2025-02-21 From printer. May be heard in committee March 23.
• 2025-03-28 Referred to Coms. on H. & C.D. and L. GOV. referral-committee
• 2025-03-28 From committee chair, with author's amendments: Amend, and re-refer to Com. on H. & C.D. Read second time and amended. amendment-introduction, amendment-passage, reading-1, reading-2
• 2025-04-01 Re-referred to Com. on H. & C.D. referral-committee
• 2025-04-24 Assembly Rule 56 suspended. (Page 1265.)
• 2025-04-24 (Pending re-refer to Com. on L. GOV.)
• 2025-04-28 From committee: Do pass and re-refer to Com. on L. GOV. with recommendation: To Consent Calendar. (Ayes 11. Noes 0.) (April 24). Re-referred to Com. on L. GOV. committee-passage, committee-passage-favorable, referral-committee
• 2025-05-01 From committee: Do pass. (Ayes 10. Noes 0.) (April 30). committee-passage, committee-passage-favorable
• 2025-05-05 Read second time. Ordered to third reading. reading-1, reading-2
• 2025-05-08 Read third time. Passed. Ordered to the Senate. (Ayes 68. Noes 0. Page 1484.) passage, reading-1, reading-3
• 2025-05-08 In Senate. Read first time. To Com. on RLS. for assignment. reading-1
• 2025-05-21 Referred to Coms. on L. GOV. and HOUSING. referral-committee
• 2025-06-23 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on L. GOV. amendment-introduction, amendment-passage, reading-1, reading-2, referral-committee
• 2025-06-24 Withdrawn from committee.
• 2025-06-24 Re-referred to Com. on RLS. referral-committee
• 2025-06-25 Re-referred to Com. on PUB. S. referral-committee
• 2025-07-15 From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 6. Noes 0.) (July 15). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
• 2025-08-19 From committee: Be ordered to second reading pursuant to Senate Rule 28.8. committee-passage, reading-2
• 2025-08-20 Read second time. Ordered to third reading. reading-1, reading-2
• 2025-09-02 Read third time and amended. Ordered to second reading. amendment-passage, reading-1, reading-3
• 2025-09-03 Read second time. Ordered to third reading. reading-1, reading-2
• 2025-09-10 Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 1. Page 2796.). passage, reading-1, reading-3
• 2025-09-10 In Assembly. Concurrence in Senate amendments pending.
• 2025-09-11 Re-referred to Com. on PUB. S. pursuant to Assembly Rule 77.2. referral-committee
• 2025-09-11 Joint Rule 62(a), file notice suspended. (Page 3319.)
• 2025-09-12 From committee: That the Senate amendments be concurred in. (Ayes 9. Noes 0.) (September 12). committee-passage
• 2025-09-13 Joint Rules 61(a)(14) and 51(a)(4) suspended. (Ayes 59. Noes 20. Page 3413.)
• 2025-09-13 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 74. Noes 0. Page 3505.). amendment-passage, committee-passage-favorable
• 2025-09-24 Enrolled and presented to the Governor at 3 p.m.
• 2025-10-01 Approved by the Governor. executive-signature
• 2025-10-01 Chaptered by Secretary of State - Chapter 183, Statutes of 2025. became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ab80ac3a-9a39-4578-8e1e-3d1bd43a1acd. Confidence: reported (aggregated from official California legislature records).